Executives
?
Darby John Patrick
EVP, Gen Counsel & Secretary
Encompass Health Corporation
US, Birmingham [HQ]
CIK
1664699
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
78,856
Price per Share :
$94.74
Equivalence :
$7,470,817.44
Transaction History
-
F78,856 Shares After TransactionValue : $7,282,351.60$546,434.95Transaction Date : 01/01/25
-
Footnotes
-
-
Footnotes:#1 These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.
-
M99,316 Shares After TransactionValue : $2,886,122.96$422,619.58Transaction Date : 05/06/24
-
Footnotes
-
-
Footnotes:#1 This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.91 to $84.06, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
-
S84,773 Shares After TransactionValue : $7,115,845.62Sold $1,220,739.42Transaction Date : 05/06/24
-
Footnotes
-
-
Footnotes:#1 This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.91 to $84.06, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
-
A81,961 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/28/24
-
Footnotes
-
-
Footnotes:#1 This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 25, 2022.#2 Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.
-
A84,773 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/28/24
-
Footnotes
-
-
Footnotes:#1 This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 25, 2022.#2 Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.